This negative feedback mechanism is supported by studies that show MAFbx ubiquitinates and targets calcineurin for degradation, thereby attenuating if not reversing cardiac hypertrophy in mouse models (Li et al., 2007; Baskin et al., 2014). This evidence concerns the gene FBXO32 and cardiac hypertrophy.